Avoid MBL Infra IPO: Hem Securities

Published on Fri, Nov 27, 2009 at 17:47 |  Source : Moneycontrol.com

Updated at Fri, Nov 27, 2009 at 17:49  

1038 Investors following MBL Infra. Share this News with them.
0
0
Share on Tumblr
Avoid MBL Infra IPO: Hem Securities

Hem Securities has come out with a research report on MBL Infra's IPO. The research firm has recommended avoiding the issue. The IPO of 57,00,000 equity shares of Rs 10 each at a price band of Rs 165-180, opened for subscription. This issue will close on December 1, 2009.

"The company is bringing the issue at price of Rs 165-180 per share which will turn into P/E multiple of 8.39-9.16 at post issue EPS of Rs 19.65(Basis PAT annualized for 3 months ending 30.06.2009). Although the company has shown decent financial performance from last few years but the high debt burden of the company is a major cause of concern. Also, looking at the peers the issue looks fully priced at present levels; hence we recommend the investor to avoid the issue", says Hem Securities.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

To read the full report click on the attachment

Attachments : MBL Infra.pdf

  

More on Moneycontrol

Trending News

Business News

Government to directly check BBM and other IM services
Competition ahoy: Monkey 1, Sensex in neck-and-neck race "Competition ahoy: Monkey 1, Sensex in neck-and-neck race"

From DJ Greek Fin Min Says Feb 17 Final Day For Greek Bond Exchange Offer

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 10 2012, 21:39

Tulsian buys steel stocks; negative on sugar, ADAG

- in MARKET OUTLOOK

Feb 10 2012, 21:39

Truck demand sluggish; margins down 80bps: Shriram Trans

- in Results Boardroom

Interviews

Feb 11 2012, 11:52 | Source: CNBC-TV18

TCS to expand centers in N.America; CY12 focus on Japan  

Feb 10 2012, 15:43 | Source: CNBC-TV18

Growth in margins sustainable going forward: Shasun Pharma  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com